Center for Drug Safety & Effectiveness
Drawing on the combined expertise of the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins School of Medicine, the Center for Drug Safety and Effectiveness serves as a nexus for individuals at Johns Hopkins who are involved in research, education, clinical programs and public service to improve prescription drug use and pharmaceutical policy in the United States and around the world. The unparalleled knowledge base of the Center’s core faculty reflects a diversity of fields, ranging from pharmacovigilance to regulatory policy.
- Drugmakers Push Profitable, but Unproven, Painkillers
The Detroit News, January 2, 2017
- Off-Label Use: Should Drugs Do Double Duty?
Consumer Reports, December 29, 2016
- Mandatory Participation Killed the Part B Demo
Modern Healthcare, December 16, 2016
- US Toughens Rules for Clinical-Trial Transparency
Nature, September 16, 2016
- Lack of Regulation Allows Pharmaceutical Companies to Raise Prices of Lifesaving Drugs, Expert Says
Wisconsin Public Radio, September 6, 2016